https://www.alphaview.kr 실시간 미국 주식 뉴스를 AI로 분석하여 시장 정보를 제공합니다. ko Sun, 25 Oct 2026 18:44:52 GMT https://www.alphaview.kr/images/brand/logo.png https://www.alphaview.kr Copyright 2026 AlphaView. All rights reserved. contact@alphaview.kr (AlphaView) contact@alphaview.kr (AlphaView) 30 https://www.alphaview.kr/news/35306-benitec-biopharma-2026년-3분기-재무-결과-발표-및-운영-업데이트-제공 Thu, 14 May 2026 12:00:00 GMT https://www.alphaview.kr/news/35306-benitec-biopharma-2026년-3분기-재무-결과-발표-및-운영-업데이트-제공 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/32135-베니텍-바이오파마-opmd-치료제-bb-301의-중간-1b2a-임상-연구-결과-고용량군-구두-발표-및-저용량군-지속적-개선-결과-발표-예정 Tue, 28 Apr 2026 11:02:47 GMT https://www.alphaview.kr/news/32135-베니텍-바이오파마-opmd-치료제-bb-301의-중간-1b2a-임상-연구-결과-고용량군-구두-발표-및-저용량군-지속적-개선-결과-발표-예정 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/16628-benitec-biopharma-고용량-bb-301에-대한-긍정적인-중간-1b2a-임상-결과-발표-및-2026년-근육영양장애협회-임상-및-과학 Mon, 09 Mar 2026 11:03:26 GMT https://www.alphaview.kr/news/16628-benitec-biopharma-고용량-bb-301에-대한-긍정적인-중간-1b2a-임상-결과-발표-및-2026년-근육영양장애협회-임상-및-과학 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/9983-benitec-biopharma-근육영양장애학회-임상-및-과학-학회에서-bb-301-1b2a-임상-시험에-대한-최신-초록-채택-발표 Mon, 23 Feb 2026 12:01:39 GMT https://www.alphaview.kr/news/9983-benitec-biopharma-근육영양장애학회-임상-및-과학-학회에서-bb-301-1b2a-임상-시험에-대한-최신-초록-채택-발표 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/71607-benitec-biopharma-bb-301-임상-1b2a-시험에서-긍정적인-장기-임상-연구-결과-발표-강력한-효능-및-지속적인-반응-내구성-입 Sun, 11 Jan 2026 13:00:00 GMT https://www.alphaview.kr/news/71607-benitec-biopharma-bb-301-임상-1b2a-시험에서-긍정적인-장기-임상-연구-결과-발표-강력한-효능-및-지속적인-반응-내구성-입 바이오/헬스케어 globenewswire GlobeNewswire